Venova Medical Announces First Subjects Enrolled in VENOS-2 IDE Study of the Velocity Percutaneous AVF System
January 17, 2025
The VENOS-2 prospective, multicenter study is being performed under an Investigational New Drug (IND) granted by the FDA and will evaluate the feasibility of the company's Velocity pAVF System, which is designed to enable a minimally invasive approach for the creation of an AV fistula for hemodialysis vascular access.